Success Metrics

Clinical Success Rate
85.7%

Based on 18 completed trials

Completion Rate
86%(18/21)
Active Trials
0(0%)
Results Posted
56%(10 trials)
Terminated
3(12%)

Phase Distribution

Ph early_phase_1
1
4%
Ph not_applicable
4
16%
Ph phase_1
2
8%
Ph phase_2
2
8%
Ph phase_3
8
32%
Ph phase_4
8
32%

Phase Distribution

3

Early Stage

2

Mid Stage

16

Late Stage

Phase Distribution25 total trials
Early Phase 1First-in-human
1(4.0%)
Phase 1Safety & dosage
2(8.0%)
Phase 2Efficacy & side effects
2(8.0%)
Phase 3Large-scale testing
8(32.0%)
Phase 4Post-market surveillance
8(32.0%)
N/ANon-phased studies
4(16.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.3%

18 of 23 finished

Non-Completion Rate

21.7%

5 ended early

Currently Active

0

trials recruiting

Total Trials

25

all time

Status Distribution
Completed(18)
Terminated(5)
Other(2)

Detailed Status

Completed18
Terminated3
Withdrawn2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
25
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.0%)
Phase 12 (8.0%)
Phase 22 (8.0%)
Phase 38 (32.0%)
Phase 48 (32.0%)
N/A4 (16.0%)

Trials by Status

withdrawn28%
completed1872%
terminated312%
unknown28%

Recent Activity

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT02115074Phase 1

Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas

Completed
NCT05965492Phase 3

Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery

Withdrawn
NCT05974501Phase 4

Pre vs Post Block in Total Knee Arthroplasty (TKA)

Completed
NCT03859024Phase 4

Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty

Completed
NCT05930080Phase 3

Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial

Completed
NCT03563690Not Applicable

Different Kinds of Acupuncture Treatment for Knee Osteoarthritis

Completed
NCT03351439Not Applicable

Efficacy of Multimodal Analgesia Following Hip Arthroscopy

Completed
NCT03472469Phase 4

MAST Trial: Multi-modal Analgesic Strategies in Trauma

Completed
NCT01901679Early Phase 1

Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women

Completed
NCT02780323Phase 4

Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis

Completed
NCT01258868Phase 1

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas

Terminated
NCT01129245Not Applicable

The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation

Completed
NCT03184493Phase 3

Celebrex and Metformin for Postoperative Hepatocellular Carcinoma

Unknown
NCT01934933Phase 4

Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis

Completed
NCT00664690Phase 4

Effect of Celecoxib on Transitional Pain After Outpatient Surgery

Withdrawn
NCT00177866Phase 4

Safety of Celecoxib in Patients With Crohn's Disease

Terminated
NCT02110719Phase 4

Decreasing Narcotics in Advanced Pelvic Surgery

Completed
NCT00614406Not Applicable

The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle

Completed
NCT00592319Phase 2

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

Terminated
NCT00664560Phase 3

Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis

Completed

Drug Details

Intervention Type
DRUG
Total Trials
25